The mid-size pharmaceutical market in South & Central America is expected to grow from US$ 24,301.56 million in 2022 to US$ 31,118.17 million by 2028; it is estimated to grow at a CAGR of 4.2% from 2022 to 2028.
The South & Central America mid-size pharmaceutical market is segmented into Brazil, Argentina, and the Rest of South & Central America. In the global market, SAM held the second smallest share of US$ 24,301.56 million in 2022. The growth of the SAM market is driven by the increasing prevalence of cancer, rising geriatric population, surging incidence of hypertension, and the growing prevalence of other chronic diseases. The mid-size pharmaceutical market in the Rest of South & Central America is sub segmented into Peru, Chile, Bolivia, Ecuador, and other countries. According to the GLOBOCAN 2020, prostate cancer is the leading cause of cancer death in the Peruvian population, with an age-standardized mortality rate (ASMR) of 44.3 per 100,000. Due to the rising cancer prevalence, the demand for oncology drugs is expected to rise in the region, which would create lucrative opportunities for the mid-size pharmaceutical companies.
By introducing new features and technologies, vendors in the South & Central America mid-size pharmaceutical market can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the market growth at a good CAGR during the forecast period.
South & Central America Mid-Size Pharmaceutical Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Mid-Size Pharmaceutical Market Segmentation
The South & Central America mid-size pharmaceutical market is segmented on the basis of type, drug development type, formulation, therapy class, and country.
Based on type, the South & Central America mid-size pharmaceutical market is bifurcated into prescription and over-the-counter. In 2022, the over-the-counter segment accounted for a larger market share. Based on drug development type, the market is bifurcated into in-house and outsource. The outsource segment held a larger market share in 2022. Based on formulation, the South & Central America mid-size pharmaceutical market is segmented into tablets and capsules, injectables, sprays, and other formulations. The tablets & capsules segment held the largest market share in 2022. Based on therapy class, the market is segmented into cardiovascular diseases, pain management, diabetes, cancer, and other conditions. The diabetes segment held the largest market share in 2022. Based on country, the South & Central America mid-size pharmaceutical market is segmented into Brazil, Argentina, and Rest of South & Central America. Brazil held the largest market share in 2022.
Alexion Pharmaceuticals, Inc.; Bausch Health Companies Inc.; Daiichi Sankyo Company Limited; Endo Pharmaceuticals Inc.; Mallinckrodt; and Sun Pharmaceutical Industries Ltd are among the leading companies operating in the mid-size pharmaceutical market in the region.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 24,301.56 Million |
| Market Size by 2028 | US$ 31,118.17 Million |
| CAGR (2022 - 2028) | 4.2% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South & Central America Mid-Size Pharmaceutical Market is valued at US$ 24,301.56 Million in 2022, it is projected to reach US$ 31,118.17 Million by 2028.
As per our report South & Central America Mid-Size Pharmaceutical Market, the market size is valued at US$ 24,301.56 Million in 2022, projecting it to reach US$ 31,118.17 Million by 2028. This translates to a CAGR of approximately 4.2% during the forecast period.
The South & Central America Mid-Size Pharmaceutical Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Mid-Size Pharmaceutical Market report:
The South & Central America Mid-Size Pharmaceutical Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Mid-Size Pharmaceutical Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Mid-Size Pharmaceutical Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South & Central America Mid-Size Pharmaceutical Market
